Recent News

• 08.13.2025 - Applied Therapeutics Reports Second Quarter 2025 Financial Results
• 08.13.2025 - Applied Therapeutics Reports Second Quarter 2025 Financial Results
• 08.13.2025 - Applied Therapeutics Reports Second Quarter 2025 Financial Results
• 06.17.2025 - Applied Therapeutics Announces Key Leadership Appointments
• 06.17.2025 - Applied Therapeutics Announces Key Leadership Appointments
• 06.17.2025 - Applied Therapeutics Announces Key Leadership Appointments
• 05.18.2025 - Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
• 05.18.2025 - Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

Recent Filings

• 08.12.2025 - 8-K Current report
• 07.29.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 07.16.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 07.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.17.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.17.2025 - 8-K Current report
• 06.17.2025 - 3 Initial statement of beneficial ownership of securities
• 06.17.2025 - EX-99.1 EX-99.1
• 06.12.2025 - 8-K Current report
• 06.11.2025 - 4 Statement of changes in beneficial ownership of securities